← Back
$FENC All transactions

FENNEC PHARMACEUTICALS INC.

A

$ Value

$692K

Shares

120,000

Price

$6

Filed

Apr 2

Insider

Name

Andrade Robert

Title

CHIEF FINANCIAL OFFICER

CIK

0001468308

Roles

Officer

Transaction Details

Transaction Date

2026-03-31

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

921,045

Footnotes

Represents settlement of PSUs that vested on March 31, 2026. | Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024. | Represents shares released from restriction from shares awarded 3/28/2025. | On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan. | One-third of the shares subject to this option may be exercised as of March 31, 2027 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested.

Filing Info

Accession No.

0001468308-26-000018

Form Type

4

Issuer CIK

0001211583

Andrade Robert's History

Date Ticker Type Value
2026-03-31 FENC M $0
2026-03-31 FENC M $0
2026-03-31 FENC A $692K
2026-03-28 FENC M $0
2026-03-26 FENC M $67K
2026-03-26 FENC M $67K
2026-02-28 FENC A $0
2026-02-18 FENC M $10K
2026-02-18 FENC M $0
2026-02-18 FENC M $10K

Other Insiders at FENC (90d)

Insider Bought Sold Last
Andrade Robert
CHIEF FINANCIAL OFFICER
2026-03-31
Raykov Rosty $234K 2026-04-01
Hackman Jeffrey S.
Chief Executive Officer
2026-03-31
Evans Terry L
Chief Commercial Officer
2026-03-31
Sayad Pierre Sargis
Chief Medical Officer
2026-03-31
Cioffi Christiana Marie
Chief Strategy Officer
2026-03-31